Samrat Pharmachem Balance Sheet Health
Financial Health criteria checks 5/6
Samrat Pharmachem has a total shareholder equity of ₹632.6M and total debt of ₹200.3M, which brings its debt-to-equity ratio to 31.7%. Its total assets and total liabilities are ₹1.1B and ₹472.3M respectively. Samrat Pharmachem's EBIT is ₹772.0K making its interest coverage ratio 0.3. It has cash and short-term investments of ₹3.7M.
Key information
31.7%
Debt to equity ratio
₹200.28m
Debt
Interest coverage ratio | 0.3x |
Cash | ₹3.66m |
Equity | ₹632.57m |
Total liabilities | ₹472.33m |
Total assets | ₹1.10b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530125's short term assets (₹919.5M) exceed its short term liabilities (₹466.6M).
Long Term Liabilities: 530125's short term assets (₹919.5M) exceed its long term liabilities (₹5.7M).
Debt to Equity History and Analysis
Debt Level: 530125's net debt to equity ratio (31.1%) is considered satisfactory.
Reducing Debt: 530125's debt to equity ratio has reduced from 38.2% to 31.7% over the past 5 years.
Debt Coverage: 530125's debt is well covered by operating cash flow (37.7%).
Interest Coverage: 530125's interest payments on its debt are not well covered by EBIT (0.3x coverage).